<DOC>
	<DOCNO>NCT01856985</DOCNO>
	<brief_summary>These pilot study design open label study investigate acceptability 200 mg mifepristone follow 24-48 hour later either 1 ) 800 µg misoprostol administer buccally 2 ) 800 µg misoprostol administer sublingually medical abortion gestation 78-84 day ' LMP . They do consecutively . Findings pilot study guide development large , multi-site study investigate efficacy outpatient medical abortion regimen woman gestation 78 - 84 day LMP . In end , pilot seek collect information acceptability outpatient medical abortion regimen 200 mg oral mifepristone follow either 800 mcg misoprostol deliver either buccally sublingually safe acceptable ? Women 's rating tolerability side effect also document .</brief_summary>
	<brief_title>Acceptability Out-patient Regimen Medical Abortion With Mifepristone 800 Mcg Misoprostol Administered 78-84 Days Gestation</brief_title>
	<detailed_description />
	<mesh_term>Mifepristone</mesh_term>
	<mesh_term>Misoprostol</mesh_term>
	<criteria>Seeking abortion service Have intrauterine pregnancy 78 day 84 day ' LMP Be willing able sign consent form Agree comply study procedure visit schedule Be live 30 minute hospital Does meet inclusion criterion outline</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>Medical abortion</keyword>
	<keyword>Misoprostol</keyword>
	<keyword>Mifepristone</keyword>
</DOC>